文献速递细菌感染、耐药与抗菌药物医院感染防控

2012-2015年美国8个大都市区碳青霉烯类非敏感鲍曼不动杆菌

Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.
PubMed 文献 · Emerg Infect Dis · 2018-01-01

2012-2015年在美国8个大都市区开展基于实验室和人群的监测,以确定尿液或正常无菌部位培养出的碳青霉烯类非敏感鲍曼不动杆菌的发病率,并描述患者和病例的人口学与临床特征。共在537例患者中识别出621例病例,粗年发病率为1.2例/10万人。在598例数据完整的病例中,528例(88.3%)发生在过去一年有医疗机构暴露史的患者中;506例(84.6%)患者体内留置有装置。尽管发病率低于其他医疗相关病原体,但这些病例与显著的疾病负担和死亡相关。

要点

  • 2012-2015年美国8个大都市区碳青霉烯类非敏感鲍曼不动杆菌粗年发病率为1.2例/10万人。
  • 598例数据完整病例中,528例(88.3%)过去一年有医疗机构暴露史。
  • 506例(84.6%)患者体内留置有装置。

核心结论

  • 在美国8个大都市区,碳青霉烯类非敏感鲍曼不动杆菌的粗年发病率为1.2例/10万人。
  • 尽管发病率低于其他医疗相关病原体,但这些病例与显著的疾病负担和死亡相关。

研究设计与样本

  • 2012-2015年在科罗拉多州、佐治亚州、马里兰州、明尼苏达州、新墨西哥州、纽约州、俄勒冈州和田纳西州的选定大都市区开展基于实验室和人群的监测。
  • 监测对象为尿液或正常无菌部位培养出碳青霉烯类非敏感鲍曼不动杆菌的病例,并描述患者和病例的人口学与临床特征。

主要发现

  • 共在537例患者中识别出621例病例。
  • 粗年发病率为1.2例/10万人。
  • 在598例数据完整的病例中,528例(88.3%)发生在过去一年有医疗机构暴露史的患者中。
  • 506例(84.6%)患者体内留置有装置。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In healthcare settings, Acinetobacter spp. bacteria commonly demonstrate antimicrobial resistance, making them a major treatment challenge. Nearly half of Acinetobacter organisms from clinical cultures in the United States are nonsusceptible to carbapenem antimicrobial drugs. During 2012-2015, we conducted laboratory- and population-based surveillance in selected metropolitan areas in Colorado, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee to determine the incidence of carbapenem-nonsusceptible A. baumannii cultured from urine or normally sterile sites and to describe the demographic and clinical characteristics of patients and cases. We identified 621 cases in 537 patients; crude annual incidence was 1.2 cases/100,000 persons. Among 598 cases for which complete data were available, 528 (88.3%) occurred among patients with exposure to a healthcare facility during the preceding year; 506 (84.6%) patients had an indwelling device. Although incidence was lower than for other healthcare-associated pathogens, cases were associated with substantial illness and death.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Bulens SN, Yi SH, Walters MS, et al. Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015. Emerg Infect Dis. 2018. PMID: 29553339. doi:10.3201/eid2404.171461

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。